跳至主要内容
临床试验/IRCT20091012002581N10
IRCT20091012002581N10尚未招募3 期

Efficacy of 5% caffeine plus 0.025% Fluocinolone acetonide versus 0.025% Fluocinolone acetonide alone for topical treatment of chronic plaque psoriasis

Tabriz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
7 years 至 70 years(—)
性别
All

入选标准

  • Patient age over 7 years
  • No history of immunosuppression or iatrogenic
  • Not using medication or treatment methods to treat psoriasis in the two weeks before the study
  • No history of caffeine allergy
  • Not pregnant or currently breastfeeding
  • Consent to participate in the study

排除标准

  • Pregnant or lactating women
  • Aggravation of the disease during the study
  • Joint involvement during the study that requires oral treatment
  • Sensitization while using the drug during the study (such as vesicular rash, erythema, itching, etc.)

研究者

相似试验